基于蛋白质组学的α-烯醇酶鉴定为胆管癌潜在的预后标志物。
Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.
机构信息
Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
出版信息
Clin Biochem. 2012 Jul;45(10-11):827-34. doi: 10.1016/j.clinbiochem.2012.04.004. Epub 2012 Apr 19.
Abstract
OBJECTIVES
To investigate the association of expression status of α-enolase (ENO1) and clinicopathological outcomes of CCA patients.
DESIGN AND METHODS
Two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS) were used to compare differential expressed protein profiles of four human CCA cell lines and H69, a non-malignant biliary cell line, as a control. Immunohistochemical analysis was carried out in tissue-microarray of human CCA tissues (n=301).
RESULTS
We identified ENO1 in all CCA cell lines but not H69 by proteomics based. About 75% of patients with CCA showed over-expression of ENO1 in hyperplastic bile duct and the tumors compared with that in tumor-adjacent normal tissue counterparts. Moreover, over-expression of ENO1 is significantly associated with poor prognosis and tumor invasion of CCA patients.
CONCLUSIONS
ENO1 may serve as a prognostic marker to monitor the disease progression of these patients.
摘要
目的
探讨烯醇化酶（ENO1）的表达状态与 CCA 患者临床病理结局的关系。
设计与方法
采用二维凝胶电泳（2-DE）和质谱（MS）技术比较了人 CCA 细胞系和 H69（一种非恶性胆管细胞系）作为对照的差异表达蛋白图谱。对人 CCA 组织的组织微阵列（n=301）进行免疫组织化学分析。
结果
通过基于蛋白质组学的方法，我们在所有 CCA 细胞系中均鉴定到 ENO1，但在 H69 中未鉴定到。与肿瘤旁正常组织相比，约 75%的 CCA 患者的增生性胆管和肿瘤中 ENO1 呈过度表达。此外，ENO1 的过度表达与 CCA 患者的不良预后和肿瘤侵袭显著相关。
结论
ENO1 可作为监测这些患者疾病进展的预后标志物。
相似文献
1
Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.基于蛋白质组学的α-烯醇酶鉴定为胆管癌潜在的预后标志物。
Clin Biochem. 2012 Jul;45(10-11):827-34. doi: 10.1016/j.clinbiochem.2012.04.004. Epub 2012 Apr 19.
2
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.过氧化物酶 1 和埃兹蛋白-根蛋白-肌动蛋白结合磷蛋白 50 在胆管癌中的预后意义。
Hum Pathol. 2012 Oct;43(10):1719-30. doi: 10.1016/j.humpath.2011.11.021. Epub 2012 Mar 24.
3
A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.一项基于蛋白质组学的前瞻性研究，旨在鉴定胆管癌诊断的潜在生物标志物。
J Gastrointest Surg. 2013 Sep;17(9):1584-91. doi: 10.1007/s11605-013-2182-9. Epub 2013 Jul 19.
4
Annexin A1: A new immunohistological marker of cholangiocarcinoma.膜联蛋白 A1：胆管癌的一种新的免疫组织化学标志物。
World J Gastroenterol. 2013 Apr 28;19(16):2456-65. doi: 10.3748/wjg.v19.i16.2456.
5
Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.E-钙黏蛋白的缺失促进胆管癌细胞的迁移和侵袭，并作为转移的潜在标志物。
Tumour Biol. 2014 Sep;35(9):8645-52. doi: 10.1007/s13277-014-2087-6. Epub 2014 May 28.
6
Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.基于 iTRAQ 的定量蛋白质组学分析鉴定 TPD52 和 DNAJB1 为胆管癌的两种新型胆汁生物标志物。
Oncol Rep. 2019 Dec;42(6):2622-2634. doi: 10.3892/or.2019.7387. Epub 2019 Oct 23.
7
YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.YKL-40/几丁质酶-3样蛋白1与胆管癌预后不良相关，并促进胆管癌细胞的生长和迁移。
Tumour Biol. 2016 Jul;37(7):9451-63. doi: 10.1007/s13277-016-4838-z. Epub 2016 Jan 19.
8
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.SOCS3和A20在人类胆管癌中的预后作用
PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.
9
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.蛋白质组学分析鉴定出意大利肝内胆管癌患者中失调的代谢和氧化相关蛋白。
BMC Cancer. 2021 Jul 28;21(1):865. doi: 10.1186/s12885-021-08576-z.
10
High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.凋亡诱导因子3（AIFM3）在人胆管癌中的高表达，线粒体相关
Tumour Biol. 2016 Oct;37(10):13659-13667. doi: 10.1007/s13277-016-5204-x. Epub 2016 Jul 29.
引用本文的文献
1
TRPC5OS induces tumorigenesis by increasing ENO1-mediated glucose uptake in breast cancer.TRPC5OS通过增加乳腺癌中ENO1介导的葡萄糖摄取诱导肿瘤发生。
Transl Oncol. 2022 Aug;22:101447. doi: 10.1016/j.tranon.2022.101447. Epub 2022 May 16.
2
Enolase 1 differentially contributes to cell transformation in lung cancer but not in esophageal cancer.烯醇化酶1在肺癌细胞转化中具有不同作用，但在食管癌中并非如此。
Oncol Lett. 2020 Apr;19(4):3189-3196. doi: 10.3892/ol.2020.11427. Epub 2020 Mar 3.
3
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance.胰腺癌患者中ENO1的过表达及其临床和诊断意义。
Gastroenterol Res Pract. 2018 Feb 1;2018:3842198. doi: 10.1155/2018/3842198. eCollection 2018.
4
Biological Entanglement-Like Effect After Communication of Fish Prior to X-Ray Exposure.X射线照射前鱼类交流后的生物类纠缠效应。
Dose Response. 2018 Feb 15;16(1):1559325817750067. doi: 10.1177/1559325817750067. eCollection 2018 Jan-Mar.
5
Proteomic characterization of the internalization of Opisthorchis viverrini excretory/secretory products in human cells.华支睾吸虫排泄/分泌产物在人细胞内吞作用的蛋白质组学特征分析
Parasitol Int. 2017 Aug;66(4):494-502. doi: 10.1016/j.parint.2016.02.001. Epub 2016 Feb 9.
6
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.胆管癌诊断、预后和治疗的分子生物标志物的组学视角
Int J Genomics. 2015;2015:179528. doi: 10.1155/2015/179528. Epub 2015 Sep 2.
7
FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.FBXW7在结直肠癌中负向调控ENO1的表达及功能。
Lab Invest. 2015 Sep;95(9):995-1004. doi: 10.1038/labinvest.2015.71. Epub 2015 Jun 22.
8
Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.胆管癌发生中的分子靶点及其治疗意义
Oncologist. 2015 Jul;20(7):742-51. doi: 10.1634/theoncologist.2014-0442. Epub 2015 May 29.
9
Enolase-1 is a therapeutic target in endometrial carcinoma.烯醇化酶-1是子宫内膜癌的一个治疗靶点。
Oncotarget. 2015 Jun 20;6(17):15610-27. doi: 10.18632/oncotarget.3639.
10
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.α-烯醇化酶通过FAK介导的PI3K/AKT信号通路促进非小细胞肺癌细胞的糖酵解、生长、迁移和侵袭。
J Hematol Oncol. 2015 Mar 8;8:22. doi: 10.1186/s13045-015-0117-5.
本文引用的文献
1
Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma.前列腺腺癌中根蛋白和埃兹蛋白的免疫组织化学染色
BMC Clin Pathol. 2011 Jan 14;11:1. doi: 10.1186/1472-6890-11-1.
2
[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].非小细胞肺癌患者肿瘤组织及循环血浆样本中的ENO1蛋白水平
Zhongguo Fei Ai Za Zhi. 2010 Dec;13(12):1089-93. doi: 10.3779/j.issn.1009-3419.2010.12.02.
3
Prognostic implication of ezrin overexpression in myxofibrosarcomas.上皮膜蛋白过表达对黏液纤维肉瘤预后的影响。
Ann Surg Oncol. 2010 Dec;17(12):3212-9. doi: 10.1245/s10434-010-1185-y. Epub 2010 Jun 29.
4
Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker.肝内胆管细胞癌中华支睾吸虫诱导的膜联蛋白 A2 的上调及其作为预后标志物的意义。
Int J Parasitol. 2010 Aug 15;40(10):1203-12. doi: 10.1016/j.ijpara.2010.05.002. Epub 2010 May 21.
5
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.ENO1，一种潜在的头颈部癌症预后标志物，通过趋化因子 CCL20 的诱导促进转化。
Eur J Cancer. 2010 Jun;46(9):1712-23. doi: 10.1016/j.ejca.2010.03.018.
6
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.胆管癌和肝细胞癌细胞分泌蛋白质组学研究。
J Biomed Biotechnol. 2010;2010:437143. doi: 10.1155/2010/437143. Epub 2009 Dec 27.
7
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.c-Myc 调控的 HnRNP 蛋白使肿瘤中的丙酮酸激酶 mRNA 剪接发生紊乱。
Nature. 2010 Jan 21;463(7279):364-8. doi: 10.1038/nature08697. Epub 2009 Dec 13.
8
Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.肝内胆管细胞癌组织中差异表达蛋白的蛋白质组学分析
J Cell Biochem. 2009 Dec 15;108(6):1376-88. doi: 10.1002/jcb.22368.
9
A review of human carcinogens--Part B: biological agents.人类致癌物综述——B部分：生物制剂
Lancet Oncol. 2009 Apr;10(4):321-2. doi: 10.1016/s1470-2045(09)70096-8.
Zotero 插件